Archive

New Agreement to advance inhibitor of novel target with global pharma company

Physiomics is pleased to announce that it has signed a substantial new contract with a major global pharmaceutical company. The programme of studies will begin…

Physiomics launches new DrugCARD® database for oncology researchers and clinicians

Physiomics is pleased to announce that it has now launched its Drug Combinations and Regimens database. DrugCARD® collates curated publicly available pre-clinical and clinical drug…

Physiomics is recruiting: Biosimulation Scientist

We have an opportunity for a Biosimulation Scientist to join our technical team to work on projects related to drug development. Find more details…

Physiomics to collaborate with the University of Oxford and the Oxford University Hospitals NHS trust on its Virtual Tumour Clinical research program

Physiomics is pleased to announce that it has signed a collaboration agreement with the University of Oxford and the Oxford University Hospitals NHS trust to…

Physiomics to update on the Virtual Tumour Clinical platform at the 2013 NCRI Cancer Conference

Physiomics is pleased to announce that it is participating in the 2013 NCRI Cancer Conference, taking place at the BT Convention Centre, Liverpool, on 3-6…

Physiomics gains new speciality pharma customer for drug discovery research

Physiomics plc (AIM: PYC), the Oxford, UK based systems biology company, is pleased to announce that it has signed a contract with a new speciality…

Physiomics gains first large pharma customer for modelling cardiac toxicity risk

Physiomics plc (AIM: PYC), the Oxford, UK based systems biology company, is pleased to announce that it has signed a contract with its first large…

Physiomics to present on the cardiac toxicity platform at the 2013 Safety Pharmacology Society’s Annual Meeting (“SPS”)

Physiomics plc (AIM: PYC), the Oxford, UK based systems biology company, is pleased to announce that it is…

Physiomics to present at the 2013 Safety Pharmacology Society’s Annual Meeting

Dr Hitesh Mistry has been accepted to present a posters at the Safety Pharmacology Society’s 13th Annual Meeting in, which will take place September 16-19…

Physiomics wins poster award at NC3Rs/Society of Biology Symposium 2013

Physiomics plc (AIM: PYC), the Oxford, UK based systems biology company, is pleased to announce that it won the second poster prize at the NC3Rs…